Abhilasha Ramasamy is a Senior Director of Health Economics and Outcomes Research (HEOR) leading the Obesity ,non-alcoholic steatohepatitis (NASH) portfolio, and other pipeline therapeutic areas at Novo Nordisk. Abhilasha joined Novo Nordisk, Inc. in June 2017. She has over 13 years of experience
working in the Pharmaceutical industry. Prior to Novo Nordisk, Abhilasha has worked for Bayer and Allergan in varying capacities in Real World Outcomes Data Generation and HEOR roles supporting multiple therapeutic areas ranging from Oncology, Alzheimer’s disease, Schizophrenia, Bipolar Disorder,
Depression and Chronic Low Back Pain.
Abhilasha got her Pharmacy degree and Master of Science in Biological Sciences degree from Birla Institute of Technology and Science in Pilani, India and she also has a Master’s in Pharmacy Administration from the University of Toledo in Ohio.
working in the Pharmaceutical industry. Prior to Novo Nordisk, Abhilasha has worked for Bayer and Allergan in varying capacities in Real World Outcomes Data Generation and HEOR roles supporting multiple therapeutic areas ranging from Oncology, Alzheimer’s disease, Schizophrenia, Bipolar Disorder,
Depression and Chronic Low Back Pain.
Abhilasha got her Pharmacy degree and Master of Science in Biological Sciences degree from Birla Institute of Technology and Science in Pilani, India and she also has a Master’s in Pharmacy Administration from the University of Toledo in Ohio.
Activity